Supporting you with CDC updates, product guidance and more to help reduce the risk of infection transmission in your facility during this time of increased concern.
Click here for information on CDC recommendations and how PDI can help
New Prevantics® Device Swab from PDI Receives FDA 510k Market Authorization.
The ONLY Chlorhexidine Gluconate/alcohol solution that has received market authorization by the U.S. Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use on ports and hubs.
REQUEST MORE INFORMATION
A TeamSTEPPS® Approach to Infection Prevention
Earn a free CEU credit while learning about breaking down communication barriers to improve outcomes in your facility.